Search
Search Constraints
You searched for: Author/Creator Solenthaler, MaxLimit your search
- Solenthaler, Max [remove] 2
- 616.994005 1
- 616.99418005 1
- AML -- CD16 -- CD56 -- immunophenotype -- NK cell -- prognosis -- response -- survival 1
- AML acute myeloid leukemia -- allo HSCT allogenic hematopoietic stem cell transplantation -- ASR age-standardized incidence-rate -- AZA 5-Azacitidine -- CC conventional care -- CI confidence interval -- CCR cantonal cancer registries -- CMML chronic myelomonocytic leukemia -- CIR crude incidence-rate -- DEC decitabine -- ESA erythropoiesis stimulating agents -- FDA food and drug administration -- HMA hypomethylating agents -- MD-CMML MDS-type CMML -- MDS myelodysplastic syndromes -- MP-CMML MPN-type CMML -- MPN myeloproliferative neoplasms -- NICER National Institute for Epidemiology and Cancer Registration -- OS observed survival -- py person-years -- RS relative survival -- SC supportive care -- SEER surveillance, epidemiology, and end results program -- SFSO Swiss Federal Statistics Office -- SWISS cantonal cancer registries in Switzerland 1
- Cancer -- Diagnosis -- Periodicals 1
- Cancer -- Epidemiology -- Periodicals 1
- Cancer -- Prevention -- Periodicals 1
- Carcinogenesis -- Periodicals 1
- Chronic myelomonocytic leukemia -- Population-based cancer registries -- Survival -- Incidence -- Switzerland -- SEER -- HMA 1
- Hematological oncology -- Periodicals 1